299 related articles for article (PubMed ID: 8433257)
1. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
[TBL] [Abstract][Full Text] [Related]
2. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
Suomalainen K; Halinen S; Ingman T; Lindy O; Saari H; Konttinen YT; Golub LM; Sorsa T
Drugs Exp Clin Res; 1992; 18(3):99-104. PubMed ID: 1425210
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo.
Suomalainen K; Sorsa T; Ingman T; Lindy O; Golub LM
Oral Microbiol Immunol; 1992 Apr; 7(2):121-3. PubMed ID: 1326740
[TBL] [Abstract][Full Text] [Related]
4. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus.
Sorsa T; Ingman T; Suomalainen K; Halinen S; Saari H; Konttinen YT; Uitto VJ; Golub LM
J Clin Periodontol; 1992 Feb; 19(2):146-9. PubMed ID: 1318330
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases.
Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT
Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785
[TBL] [Abstract][Full Text] [Related]
6. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva.
Golub LM; Sorsa T; Lee HM; Ciancio S; Sorbi D; Ramamurthy NS; Gruber B; Salo T; Konttinen YT
J Clin Periodontol; 1995 Feb; 22(2):100-9. PubMed ID: 7775665
[TBL] [Abstract][Full Text] [Related]
8. Non-proteolytic activation of latent human neutrophil collagenase and its role in matrix destruction in periodontal diseases.
Sorsa T; Saari H; Konttinen YT; Suomalainen K; Lindy S; Uitto VJ
Int J Tissue React; 1989; 11(4):153-9. PubMed ID: 2561361
[TBL] [Abstract][Full Text] [Related]
9. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems.
Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266
[TBL] [Abstract][Full Text] [Related]
10. Host modulation with tetracyclines and their chemically modified analogues.
Golub LM; Suomalainen K; Sorsa T
Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
[TBL] [Abstract][Full Text] [Related]
11. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate.
Teronen O; Konttinen YT; Lindqvist C; Salo T; Ingman T; Lauhio A; Ding Y; Santavirta S; Sorsa T
J Dent Res; 1997 Sep; 76(9):1529-37. PubMed ID: 9294486
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T
J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658
[TBL] [Abstract][Full Text] [Related]
13. [Clinical use of tetracyclines in the treatment of periodontal diseases].
Bokor-Bratić M; Brkanić T
Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases.
Nomura T; Ishii A; Oishi Y; Kohma H; Hara K
Oral Dis; 1998 Dec; 4(4):231-40. PubMed ID: 10200701
[TBL] [Abstract][Full Text] [Related]
15. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome.
Halinen S; Sorsa T; Ding Y; Ingman T; Salo T; Konttinen YT; Saari H
J Periodontol; 1996 Aug; 67(8):748-54. PubMed ID: 8866313
[TBL] [Abstract][Full Text] [Related]
16. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis.
Gangbar S; Overall CM; McCulloch CA; Sodek J
J Periodontal Res; 1990 Sep; 25(5):257-67. PubMed ID: 2170617
[TBL] [Abstract][Full Text] [Related]
17. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.
Rifkin BR; Vernillo AT; Golub LM
J Periodontol; 1993 Aug; 64(8 Suppl):819-27. PubMed ID: 8410621
[TBL] [Abstract][Full Text] [Related]
18. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients.
Nakamura T; Kido J; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T
J Periodontol; 2000 Mar; 71(3):361-7. PubMed ID: 10776922
[TBL] [Abstract][Full Text] [Related]
19. Activation of neutrophil collagenase in periodontitis.
Romanelli R; Mancini S; Laschinger C; Overall CM; Sodek J; McCulloch CA
Infect Immun; 1999 May; 67(5):2319-26. PubMed ID: 10225890
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and their inhibition in periodontal treatment.
Ryan ME; Ramamurthy S; Golub LM
Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
